Universal Display Corporation: Q3 2023 Form 10-Q Summary
Business Context and Reporting Period
Universal Display Corporation develops, licenses and commercializes OLED technologies and materials for display and lighting applications. Its principal revenue sources are OLED material sales, royalty and license fees, technology development and support, and contract research services through Adesis. The filing covers the three and nine months ended September 30, 2023, compared with the corresponding 2022 periods. The financial statements are unaudited.
Financial Performance and Key Metrics
| Metric | Q3 2023 | Q3 2022 | Nine Months 2023 | Nine Months 2022 |
|---|---|---|---|---|
| Total revenue | $141.1 million | $160.6 million | $418.1 million | $447.6 million |
| Material sales | $92.5 million | $84.2 million | $239.8 million | $242.7 million |
| Royalty and license fees | $45.9 million | $71.5 million | $165.5 million | $191.5 million |
| Gross margin | $106.8 million; 76% | $123.2 million; 77% | $318.8 million; 76% | $349.8 million; 78% |
| Operating income | $48.4 million | $68.5 million | $152.4 million | $184.0 million |
| Net income | $51.5 million | $53.5 million | $141.0 million | $144.9 million |
| Diluted EPS | $1.08 | $1.12 | $2.95 | $3.04 |
| Operating cash flow | Not separately provided | Not separately provided | $117.7 million | $124.2 million |
Q3 revenue declined 12% year over year, while nine-month revenue declined 7%. Material sales increased 10% in Q3, supported by stronger OLED demand and product mix, but declined 1% for the nine-month period due primarily to weaker first-quarter demand. Q3 material unit volume increased 3%; nine-month unit volume decreased 3%.
Q3 royalty and license revenue decreased 36%, and nine-month royalty and license revenue decreased 14%. The changes reflected customer mix, estimates of future customer demand and lower cumulative catch-up adjustments under long-term contracts. Interest income increased to $7.1 million in Q3 and $20.3 million for the nine-month period, driven by higher yields and investment balances.
Research and development expense increased to $33.1 million in Q3 and $96.8 million for the nine-month period. Nine-month selling, general and administrative expense decreased to $50.6 million. The effective tax rate was 4.4% in Q3 and 16.8% for the nine-month period, benefiting primarily from a July 2023 IRS regulatory change allowing certain withholding taxes to be credited against U.S. taxable income.
Liquidity, Capital Resources and Balance Sheet
- Cash and cash equivalents were $79.3 million at September 30, 2023, compared with $93.4 million at December 31, 2022.
- Short-term investments were $412.4 million and long-term corporate and government bond investments were $287.1 million, producing total cash, cash equivalents and investments of approximately $778.8 million.
- Working capital was $747.4 million at September 30, 2023, compared with $763.8 million at year-end 2022.
- Total liabilities were $240.6 million and shareholders’ equity was $1.382 billion. The filing does not report conventional borrowings or debt; operating lease liabilities totaled $26.8 million.
- Cash used in investing activities was $75.4 million, including $52.2 million for property and equipment, $66.6 million for intangible assets and net investment purchases of $43.4 million.
- Cash used in financing activities was $56.4 million, including $50.1 million of dividends. The company declared a fourth-quarter dividend of $0.35 per share payable December 29, 2023.
- Management expects existing cash, cash equivalents and short-term investments to fund obligations for at least the next twelve months.
Material Changes Versus the Prior Comparable Period
- Revenue and operating income decreased primarily because of lower royalty and license fees.
- Gross margin declined to 76% from 77% in Q3 and to 76% from 78% for the nine-month period.
- Q3 material sales improved, but nine-month material sales and volumes remained below the prior year because of unfavorable macroeconomic conditions affecting the OLED display market.
- Shannon, Ireland manufacturing-facility underutilization charges increased to $10.6 million for the nine-month period from $4.5 million. The facility was purchased during September 2023 and is expected, when fully operational, to double production capacity and diversify manufacturing.
- On April 28, 2023, the company acquired more than 550 OLED-related patents and patent applications from Merck KGaA for $66.0 million, recorded as acquired technology and amortized over ten years.
- Property and equipment increased primarily from purchasing the Shannon facility and a Korean application center.
Guidance, Outlook, Risks and Unusual Items
The filing does not provide specific revenue or earnings guidance. Management expects quarterly results to fluctuate based on material sales volumes, licensing and royalty timing, research and development and patent expenditures, and new business relationships.
- Revenue is highly concentrated: four customers represented 85% of Q3 revenue and 85% of nine-month revenue. Approximately 98% of revenue was generated outside North America.
- Substantially all chemical materials were purchased from one supplier. Inventory commitments were $26.2 million at September 30, 2023.
- Inventory reserves increased by $6.6 million during the nine-month period because of excess inventory in certain products.
- The company recorded a $57.6 million long-term tax receivable related to a disputed Korean withholding-tax refund. The Korean tax authority rejected the refund request, and the company is pursuing an appeal. A related U.S. tax liability of $15.7 million was recorded.
- The company has $30.5 million of committed customer purchase orders for phosphorescent emitter materials expected to be fulfilled within 90 days.
- Patent challenges and opposition proceedings occur in the ordinary course and may result in affirmation, denial or modification of patent claims.
- The company states that there were no material changes to previously disclosed risk factors, no material off-balance-sheet arrangements and no material changes to internal control over financial reporting.
Important Facts for Investors to Verify
- Whether the recent improvement in material sales is sustained and offsets continuing pressure on royalty and license revenue.
- The timing and magnitude of OLED display-market recovery, particularly in South Korea and China, which together accounted for most revenue.
- Progress, utilization and spending requirements at the Shannon manufacturing facility.
- The outcome and timing of the Korean withholding-tax refund appeal and related U.S. tax consequences.
- Customer concentration, minimum purchase and royalty obligations, and the effect of contract-estimate changes on reported revenue.
- Potential inventory write-downs, supplier concentration and the company’s ability to maintain high gross margins while funding research, patent development and commercialization initiatives.